Cargando…
P2RX7 Purinoceptor as a Therapeutic Target—The Second Coming?
The P2RX7 receptor is a unique member of a family of extracellular ATP (eATP)-gated ion channels expressed in immune cells, where its activation triggers the inflammatory cascade. Therefore, P2RX7 has been long investigated as a target in the treatment of infectious and inflammatory diseases. Subseq...
Autores principales: | Young, Chris N. J., Górecki, Dariusz C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032550/ https://www.ncbi.nlm.nih.gov/pubmed/30003075 http://dx.doi.org/10.3389/fchem.2018.00248 |
Ejemplares similares
-
P2RX7 Purinoceptor: A Therapeutic Target for Ameliorating the Symptoms of Duchenne Muscular Dystrophy
por: Sinadinos, Anthony, et al.
Publicado: (2015) -
Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism
por: Al-Khalidi, Rasha, et al.
Publicado: (2018) -
The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular Dystrophies
por: Zabłocki, Krzysztof, et al.
Publicado: (2023) -
P2X7 Purinoceptor Affects Ectopic Calcification of Dystrophic Muscles
por: Rumney, Robin M. H., et al.
Publicado: (2022) -
P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatment
por: Young, Christopher N J, et al.
Publicado: (2012)